Results 91 to 100 of about 3,528 (147)

Humoral Immune Response Induced by the BBIBP-CorV Vaccine (Sinopharm) in Healthcare Workers: A Cohort Study

, 2022
Insufficient data have been reported about the effect of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) on the humoral response through time in healthcare workers (HCW).
Cesar Copaja-Corzo, Hueda-Zavaleta, Miguel, José Alonso Cáceres-DelAguila, Daniella Arenas Siles, De La Cruz-Escurra, Nathalia, Benites-Zapata, Vicente A, Juan C. Gómez de la Torre, Gómez de la Torre, Juan C., Copaja-Corzo, Cesar, Copaja-Corzo, C., Cáceres-DelAguila, José Alonso, De La Cruz-Escurra, N., Siles, D.A., Miguel Hueda-Zavaleta, Cáceres-Delaguila, J.A., Arenas Siles, Daniella, Muro-Rojo, Cecilia, Hueda-Zavaleta, M., Nathalia De La Cruz-Escurra, Vicente A Benites-Zapata, Benites-Zapata, V.A., Cecilia Muro-Rojo, Gómez de la Torre, J.C., Muro-Rojo, C.   +23 more
core   +1 more source

Antineutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis following COVID-19 BBIBP-CorV vaccine: A case report

COVID-19 and its vaccination could initiate autoimmunity including ANCA-associated vasculitis that could mimic COVID-19 infection symptoms. This misdiagnosis could increase the morbidity of AAV.
Mina Borran, Vahid Reisi-Vanani, Fadaei-Tirani, Negin, Amoosoltani-Forooshani, Zainab, Javadian, Parisa, Zainab Amoosoltani-Forooshani, Negin Fadaei-Tirani, Parisa Javadian, Borran, Mina, Reisi-Vanani, Vahid   +9 more
core   +1 more source

Effects of BBIBP-CorV vaccine on gut microbiota and short-chain fatty acids in mice exposed to bis (2-ethylhexyl) phthalate and dioctyl terephthalate

Environment International
As the COVID-19 pandemic has progressed, increasing evidences suggest that the gut microbiota may play a crucial role in the effectiveness of SARS-CoV-2 vaccine.
Miaomiao Teng, Jiaqi Sun, Lihui Zhao, Yunxia Li, Zixuan Zhang, Wentao Zhu, Yuntao Zhang, Fangjingwei Xu, Sixi Xing, Xiaoli Zhao, Fengchang Wu   +10 more
doaj   +1 more source

Factores de riesgo para la presencia de Eventos Supuestamente Atribuidos a la Vacunación o Inmunización (ESAVI) en la vacunación con BBIBP-CorV contra COVID-19 en Trabajadores de EsSalud en La Libertad en 2021 [PDF]

, 2023
La vacuna BBIBP-CorV fue la primera vacuna para COVID-19 que llegó al Perú, sin embargo, generó muchas dudas en la población sobre su seguridad por su aprobación antes de cumplir con todas las fases correspondientes.
Solar Camacho, Marco Antonio Luis
core  

Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study

, 2022
A COVID-19 booster vaccination is being comprehensively evaluated globally due to the emerging concern of reduced protection rate of previous vaccination and circulating Variants of Concern (VOC).
Yi Zhang (9093), Mingxiang Fan (11954626), Wenhong Zhang (207387), Qiran Zhang (9287648), Hongyu Wang (366946), Jieyu Song (11954620), Yang Zhou (65942), Haocheng Zhang (1573942), Zhangfan Fu (11954617), Jingwen Ai (6270965), Ke Lin (167518), Xiaohua Chen (257762), Yuanhan Zhao (11954623), Chao Qiu (135426)   +13 more
core   +1 more source

A real-world study on the effectiveness of BBIBP-CorV and CoronaVac in Nanjing area. [PDF]

Sci Rep, 2023
Huang M, Jia L, Ye S, Pang R, Ma C, Zhang J, Dai S, Zhang K, Dai Y, Fu Q, Zhang L.   +10 more
europepmc   +1 more source

Cord blood antibodies following BBIBP-CorV (Sinopharm) vaccination during pregnancy. [PDF]

Immun Inflamm Dis, 2023
Hantoushzadeh S, Eshraghi N, Younesi S, Salehi M, Rezaei N, Hasheminejad MM, Rashidian P, Shirdel S, Asadi F, Ghaemi M.   +9 more
europepmc   +1 more source

Assessment of the factors affecting the clinical outcomes of infection and safety of vaccines against SARS-CoV-2 among Egyptian patients

BMC Infectious Diseases
Background Understanding the factors that influence clinical outcomes of COVID-19 and the safety of various vaccines is important to inform public health strategies, particularly in diverse communities.
Amira A. Zidan, Ahmed Yousef Jad, Nermine H. Zakaria, Hazem M. El-Hariri, Maged El-Setouhy   +4 more
doaj   +1 more source

Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka. [PDF]

Immunology, 2022
Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Tanussiya S, Kuruppu H, Ranasinghe T, Dayarathne S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Madusanka D, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN.   +31 more
europepmc   +1 more source

Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV. [PDF]

Cureus, 2023
Wijekoon L, Sarathchandra C, Siribaddana S.   +2 more
europepmc   +1 more source